Main Menu
Menu

Op-Eds

Publish Date
The Law is Clear: There’s No Legal Authority to Control Prices Via Bayh-Dole
RealClearPolicy
Paul R. Michel
America’s 21st Century Sputnik Moment
RealClearPolicy
Walter G. Copan and Andrei Iancu
Removing patent rights to lower drug costs is dangerous precedent
The Denver Post
Walter G. Copan
U.S. patent system weakens: Protect IP to keep American tech at the top
VentureBeat
Paul R. Michel
China’s formidable technology challenge
International Business Times
Paul R. Michel
The U.S. must fix its innovation engine: the patent system
STAT
Adam Mossoff
US Economy 2022: Diversity And Inclusion For The Heartland
International Business Times
Paul R. Michel
Lawmakers want to weaken U.S. patents that made new anti-COVID pills possible. We should do everything to protect them
Fortune
Andrei Iancu, David Kappos, and Paul R. Michel
Big Tech is abusing the U.S. patent challenge system
Reuters
Paul R. Michel
Thank You, Senator Tillis, for Recognizing the Need for Evidence-Based Policymaking in Patent Law
IPWatchdog
Adam Mossoff
The Supreme Court is partly to blame for the Covid-19 test kit shortage
STAT
Paul R. Michel
Can We Please Get Serious About Patents and Drug Pricing?
RealClearPolicy
Barney Cassidy
Scroll to Top